Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic... von Fizazi, K, De Bono, J.S, Flechon, A, Heidenreich, A, Voog, E, Davis, N.B, Qi, Ming, Bandekar, R, Vermeulen, J.T, Cornfeld, M, Hudes, G.R

Volltext

P345 Systemic contact dermatitis resulting from patch testing to vanadium von Hudes, G, Karagic, M, Abramian, O, Ramesh, M

Volltext

P049 Acute interstitial pneumonitis following talc-pleurodesis von Clark, C, Hudes, G, Swedish, K

Volltext

Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer von Michaelson, M.D., Bellmunt, J., Hudes, G.R., Goel, S., Lee, R.J., Kantoff, P.W., Stein, C.A., Lardelli, P., Pardos, I., Kahatt, C., Nieto, A., Cullell-Young, M., Lewis, N.L., Smith, M.R.

Volltext

M411 ACTIVE TUBERCULOSIS (TB) MASQUERADING AS AN ASTHMA EXACERBATION DURING A SARS-COV-2 (COVID 19) PANDEMIC von Hudes, G., Beronilla, M.

Volltext

Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH ), a beta integrin antagonist, in patients with solid tumours von Cianfrocca, M E, Kimmel, K A, Gallo, J, Cardoso, T, Brown, M M, Hudes, G, Lewis, N, Weiner, L, Lam, G N, Brown, S C, Shaw, D E, Mazar, A P, Cohen, R B

Volltext

PREGABALIN ANAPHYLAXIS RELATED TO DOSING INCREASE von Amaro, O. Tejada, Hudes, G., Agress, A.

Volltext

Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer von HUDES, G. R, NATHAN, F, ROETHKE, S, MCALEER, C, KHATER, C, HAAS, N, CORNFIELD, M, GIANTONIO, B, GREENBERG, R, GOMELLA, L, LITWIN, S, ROSS, E

Volltext

Altered β-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells von RANGANATHAN, S, BENETATOS, C. A, COLARUSSO, P. J, DEXTER, D. W, HUDES, G. R

Volltext

RESOLUTION OF CHICKEN ANAPHYLAXIS IN A PATIENT TREATED WITH DUPILUMAB von Pisani, O., Ramesh, M., Ferastraoaru, D., Rosenstreich, D., Hudes, G.

Volltext

M405 COVID-19 ASSOCIATED EOSINOPHILIC LICHEN PLANUS von Hudes, G., Weingarten, M., Tejera, D. Sanchez

Volltext

M304 SOY MILK ANAPHYLAXIS IN PATIENTS WITH NEGATIVE SOY SPECIFIC IGE AND SKIN TEST: DIAGNOSTIC CHALLENGE von Hudes, G., Friedman, N., Rosenstreich, D.

Volltext

BASELINE CHARACTERISTICS OF PATIENTS FROM THE UNITED STATES WITH CRSWNP IN THE AROMA GLOBAL REGISTRY von Jang, D., Mustafa, S., Hudes, G., Davis, J., Xia, C., Corbett, M., Avigliano, M.

Volltext

The Urticaria Severity Score May Serve As An Early Clinical Indicator In Monitoring Patients With Chronic Urticaria von Ferastraoaru, D.E, Jariwala, S, Lobell, E, Parikh, P, Walters, P, Altrich, M, Hudes, G, Rosenstreich, D

Volltext

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma von Hudes, Gary, Carducci, Michael, Tomczak, Piotr, Dutcher, Janice, Figlin, Robert, Kapoor, Anil, Staroslawska, Elzbieta, Sosman, Jeffrey, McDermott, David, Bodrogi, István, Kovacevic, Zoran, Lesovoy, Vladimir, Schmidt-Wolf, Ingo G.H, Barbarash, Olga, Gokmen, Erhan, O'Toole, Timothy, Lustgarten, Stephanie, Moore, Laurence, Motzer, Robert J

Volltext

DELAYED URTICARIA AND ANGIOEDEMA FOLLOWING YELLOW FEVER VACCINE IMMUNIZATION von Beronilla, M., Karagic, M., Hudes, G.

Volltext

Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group von Roth, B J, Dreicer, R, Einhorn, L H, Neuberg, D, Johnson, D H, Smith, J L, Hudes, G R, Schultz, S M, Loehrer, P J

Volltext

UNRECOGNIZED PARASITIC INFECTION AS A CAUSE OF PERSISTENT EOSINOPHILIA IN AN INNER-CITY ALLERGY CLINIC POPULATION von Regula, P., Beronilla, M., Jakubowicz, H., Fizitskaya, A., Ferastraoaru, D., Ramesh, M., Rosenstreich, D., Hudes, G.

Volltext

Phase I Pharmacokinetic Trial of Perillyl Alcohol (NSC 641066) in Patients with Refractory Solid Malignancies von HUDES, G. R, SZARKA, C. E, MINGXIN QIAN, GALLO, J. M, ADAMS, A, RANGANATHAN, S, MCCAULEY, R. A, WEINER, L. M, LANGER, C. J, LITWIN, S, YESLOW, G, HALBERR, T

Volltext

Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer von YU, Evan Y, WILDING, George, TRUDEL, Géralyn C, PALIWAL, Prashni, STERNBERG, Cora N, POSADAS, Edwin, GROSS, Mitchell, CULINE, Stephane, MASSARD, Christophe, MORRIS, Michael J, HUDES, Gary, CALABRO, Fabio, SHINTA CHENG

Volltext